搜索筛选:
搜索耗时2.4038秒,为你在为你在102,285,761篇论文里面共找到 20 篇相符的论文内容
类      型:
[会议论文] 作者:Shimin Guo,Dengming He,Maoshi Li,Peng Zhu,Jie Wang,Yuming Wang, 来源:中华医学会第十六次全国病毒性肝炎及肝病学术会议 年份:2013
[会议论文] 作者:Shimin Guo,Dengrning He,Maoshi Li,Peng Zhu,Jie Wang,Yuming Wang, 来源:中华医学会第十六次全国病毒性肝炎及肝病学术会议 年份:2013
[会议论文] 作者:Hongfei Huang,Dengming He,Quanxin Wu,Maoshi Li,Peng Zhu,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Shimin Guo,Dengming He,Maoshi Li,Peng Zhu,Jie Wang,Yuming Wang, 来源:第三届全国病毒性肝炎慢性化重症化基础与临床研究进展学术会议 年份:2013
Objective Patients who have not obtained the effective suppression of hepatitis B virus (HBV) replication cannot have an improvement in liver histology.We aimed to explore the differences of several r...
[会议论文] 作者:Hongfei Huang,Dengming He,Quanxin Wu,Maoshi Li,Peng Zhu,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Shiqi Tao,Dengming He,Maoshi Li,Junqiu Wu,Zhaoxia Tan,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Shimin Guo,Dengming He,Maoshi Li,Peng Zhu,Jie Wang,Yuming Wang, 来源:中华医学会第十六次全国病毒性肝炎及肝病学术会议 年份:2013
Objective Patients who have not obtained the effective suppression of HBV cannot have an improvement in liver histology.The combination antiviral therapy of lamivudine plus adefovir is the recommended...
[会议论文] 作者:Shimin Guo,Dengrning He,Maoshi Li,Peng Zhu,Jie Wang,Yuming Wang, 来源:中华医学会第十六次全国病毒性肝炎及肝病学术会议 年份:2013
Objective Patients who have not obtained the effective suppression of HBV cannot have an improvement in liver histology.The combination antiviral therapy of lamivudine plus adefovir is the recommended...
[会议论文] 作者:Dengming He,Shiqi Tao,Maoshi Li,Shimin Guo,Junqiu Wu,Zhaoxia Tan,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Shiqi Tao,Maoshi Li,Shimin Guo,Junqiu Wu,Zhaoxia Tan,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Zhaoxia Tan,Maoshi Li,Shimin Guo,Peng Zhu,Xuemei Kuang,Guohong Deng,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Xianghua Zeng,Zhaoxia Tan,Shimin Guo,Yuming Wang,Guohua Yan,Maoshi Li,Cheng Xu, 来源:中华医学会第五次全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议 年份:2015
[会议论文] 作者:Dengming He,Maoshi Li,Shimin Guo,Xianghua Zeng,Zhaoxia Tan,Guohua Yan,Cheng Xu,Yuming Wang, 来源:中华医学会第五次全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议 年份:2015
Backgrounds and aims: Sodium taurocholate cotransporting polypeptide (NTCP, encoded by SLC10A1), a multiple transmembrane transporter predominantly expressed in the liver, was found as a functional re...
[会议论文] 作者:Dengming He,Zhaoxia Tan,Maoshi Li,Shimin Guo,Peng Zhu,Xuemei Kuang,Guohong Deng,Yuming Wang, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Shiqi Tao,Shimin Guo,Maoshi Li,Peng Zhu,Hongfei Huang,Jie Wang,Yuming Wang,Mingquan Ding, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Xianli Chen,Guohua Yan,Jie Wang,Maoshi Li,Shimin Guo,Peng Zhu,Hongfei Huang,Yuming Wang, 来源:第三届全国病毒性肝炎慢性化重症化基础与临床研究进展学术会议 年份:2013
  The management strategy of chronic hepatitis B in patients treated with nucleos(t)ide analogues (NAs) is a topic of concern.After achieving specific endpoin...
[会议论文] 作者:Dengming He,Shiqi Tao,Shimin Guo,Maoshi Li,Peng Zhu,Hongfei Huang,Jie Wang,Yuming Wang,Mingquan Ding, 来源:第二届全国病毒感染与器官功能衰竭学术会议 年份:2013
[会议论文] 作者:Dengming He,Yuming Wang,Wen Chen,Xianli Chen,Guohua Yan,Jie Wang,Maoshi Li,Shimin Guo,Peng Zhu,Hongfei, 来源:中华医学会第十六次全国病毒性肝炎及肝病学术会议 年份:2013
Background HBeAg-negative chronic hepatitis B (CHB) patients have active liver disease with a high risk of progression to decompensated cirrhosis and hepatocellular carcinoma.The management strategy o...
[会议论文] 作者:Dengming,Shiqi Tao,Shimin Guo,Maoshi Li,Junqiu Wu,Hongfei Huang,Guohua Yan,Peng Zhu,Cheng Xu,Yuming Wang, 来源:中华医学会第四届全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议 年份:2014
[会议论文] 作者:Dengming,Shiqi Tao,Shimin Guo,Maoshi Li,Junqiu Wu,Hongfei Huang,Xinwu Guo,Guohua Yan,Peng Zhu,Cheng Xu, 来源:中华医学会第四届全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议 年份:2014
Background and aims The innate immunity represented by TLR-IFN signal pathway play a crucial role in HBV control.Although HLA polymorphisms is associated with chronic HBV infection, no further mechani...
相关搜索: